M&A Deal Summary |
|
|---|---|
| Date | 2022-01-01 |
| Target | Pharma Nobis |
| Sector | Life Science |
| Buyer(s) | Signet Healthcare Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 600M USD |
| Size | Middle-Market |
| Type | Sector Focused |
Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 17 |
| Sector: Life Science M&A | 10 of 14 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 1 of 1 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 8 of 9 |
| Year: 2022 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-08 |
Ascendia Pharmaceuticals
North Brunswick, New Jersey, United States Ascendia Pharmaceuticals is a specialty CDMO focused on developing and manufacturing enhanced formulations for pre-clinical and clinical stage drug candidates and marketed drug products. Ascendia specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes of administration. The company has three technology platforms - EmulSol® for producing nano-emulsions, AmorSol® for creating amorphous solid dispersions, and NanoSol® for formulating nano-particles. Ascendia Pharmaceuticals was founded in 2012 and is based in North Brunswick, New Jersey. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-24 |
Juno Pharma Canada
Montreal, Quebec, Canada Juno Pharma Canada is a specialty pharmaceutical company with a focus on injectable generic drugs sold through hospital channels. Juno Pharma Canada was founded in 2012 and is based in Montreal, Quebec. |
Buy | - |
